Ignite Creation Date:
2024-05-06 @ 3:26 PM
Last Modification Date:
2024-10-26 @ 1:50 PM
Study NCT ID:
NCT04639986
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-14
First Post:
2020-11-17
Brief Title:
Asian Study of Sacituzumab Govitecan IMMU-132 in HRHER2- Metastatic Breast Cancer MBC
Sponsor:
Gilead Sciences
Organization:
Gilead Sciences
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-23
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12
Completion Date Type:
ESTIMATED
First Submit Date:
2020-11-17
First Submit QC Date:
November 17 2020
Study First Post Date:
2020-11-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-13
Last Update Post Date:
2024-06-14
Last Update Post Date Type:
ACTUAL